|
|
 |
What
could GH3 - Gerovital do for you...
- GH3 sexual
potency
- GH3
and Herpes
- GH3
and Cancer
- Heart
Attack/Stroke
- GH3
and Allergies
- GH3 Hair
Regrow/Color
-
GH3 Common Illnesses
- GH3
Depression
- Osteoporosis
- Sickle-Cell
Anaemia
- Blood
Sugar Level
- Stress
- Multiple
Sclerosis
- Body
Weight
- Life
Extension
|
Since Gerovital is a nutrient, the exact improvements are
not predictable for any one person. It works at a cellular
level and therefore the action is general rather than specific.
The
changes arising from gerovital are usually subtle. Individuals used
to the dramatic effects of synthetic drugs may not notice
the any difference day to day.
In
assessing the benefits, experience shows that it is preferable
to look back over several months. Changes in physical and
mental status then can be evaluated. Some users of the product
report remarkable benefits.
In
order to give gerovital a fair test at least a three month period
is recommended. gerovital works slowly like a vitamin and a three-month
or more period is important for a proper evaluation in a individuals
body. The "cell regeneration process" will take
effect from then onward, sometimes with spectacular results.
|
GEROVITAL
AND SEXUAL POTENCY
Some researchers believe that decreased levels of the neurotransmitter
serotonin lead to impotence.Serotonin is a substrate of MAO. Ideally,
MAO metabolises the serotonin so it will not become too prominent.
Rising levels of MAO, which may appear after age 45 thus, accompany
falling levels of serotonin. Gerovital has a demonstrated ability
to inhibit excess MAO. Thus it may tend to normalise serotonin levels
and restore potency. Estrogen and androgen production can be a factor
in sexual characteristics and performance as well. Parhon, Aslan
and Danila and Untea conducted studies in this area. They concluded
that gerovital tends to increase deficient estrogen and androgen levels.
It appears that this simulative effect only occurs where these factors
are subnormal.
-
GEROVITAL
H3 AND HERPES
To date, there is noting that will eliminate herpes. However
a relevant research study was conducted by J. Earle Officer of the
University of Southern California. He showed that herpes I and herpes
II viruses did not become active in the presence of gerovital.
-
GEROVITAL
AND CANCER
There is no definitive answer to this question. Studies by J Earl
Officer also showed that the C-type (cancer producing) viruses did
not become active during gerovital experiments. Dr Aslan reported a statistical
decrease in the appearance of neoplasms in patient populations using
gerovital long term.
-
GEROVITAL
AND HEART ATTACK/STROKE
The evidence remains inconclusive. Studies by Cohen and Ditman
and by Aslan indicated a lowering of cholesterol levels in patients
using gerovital The tendency for the product to normalise arterial pressure
and heart rate also may play a role in preventing damage to the
circulatory system. At the National Congress of Professors in Italy,
1974, the assembled scientists praised gerovital`s effectiveness against
the accumulation of blood clots and cholesterol. They also agreed
that it does not pose any health risks. Soon after beginning to
take gerovital some people show an increase in cholesterol. Importantly,
this level is measured in the blood. A temporary rise may indicate
a mobilisation of the arterial deposits.
- GEROVITAL
AND ALLERGIES
The body's immune system responds defensively to the presence
of various substances from the environment. However, it may become
sensitised to one of these antigens and over react. The normal protective
response can get out of hand. The chemical consequences of this natural
function gone awry may become an even larger problem. Histamine output
increases and this may create many of the classic symptoms of an allergic
reaction.
Additionally,
stress may leave the body open to an allergic reaction when the
adrenal glands must respond more often. This can lead to a depletion
of vital chemical defences. gerovital may moderate these problems in several
ways: (1) Researchers Ghali, Cohen and Aslan assert that gerovital is
an anti-histamic (44) (2) Bucci has demonstrated that it moderates
the adrenal response. (3) Acetylcholine is a counterpart of adrenaline.
Since DEAE is a precursor to acetylcholine , it may promote a parasympathetic
response during times of stress.
- HOW
DOES GEROVITAL MAKE HAIR REGROW AND RECOLOUR?
There is certainly ample scientific evidence that gerovital may help
recolor and regrow hair Once again, the pharmacological action is
not clearly understood. It is known that endocrine imbalances reduced
circulation can lead to the weakening and thinning of hair. Poor nutrition
or nutrition inadequately communicated to the scalp may result in
poor hair quality. As already documented, gerovital reportedly helps restore
endocrine balance. It improves circulation to all parts of the body
through vasodilatation. PABA also is believed effective in improving
hair quality.
The
ionised and stabilised nature of gerovital may allow the PABA to perform
even more effectively. The regrowing and recoloring of hair does
not occur at all in some people. Even when it does, several years
may pass before appreciable results are obtained. Nutrient or endocrine
deficiencies may not be the cause in some instances of poor hair
quality or hair loss. In these cases the product may not help.
-
WILL
GEROVITAL FORTIFY THE BODY AGAINST COMMON ILLNESS?
DR Aslan and her associates noted that 38% of subjects using gerovital
showed a reduction in absenteeism from work A two year study by
Untea and Bercu revealed that 76% of labourers doing piece work
increased their incomes during the study if they were on gerovital These
same workers experienced better concentration on the job and an
absence of fatigue. As mentioned earlier, a serious influenza epidemic
swept through Europe during one of the Romanian studies. DR Aslan
reported a mortality rate of 3.2% in patients on gerovital In the untreated
group, the mortality rate was 13.9%. An American report noted similar
results 3.3% mortality was found among gerovital users, while the untreated
group showed a 12.0% rate.
- WHAT
IS THE ROLE OF MAO IN DEPRESSION? CAN GEROVITAL CORRECT IT?
The neurotransmitters serotonin and noreprinephrine apparently are
needed for proper neural responses. Most researchers believe that
deficient levels result in depressive syndromes. This soon leads to
fatigue pessimism, withdrawal and inadequate functioning. MAO is believed
to metabolise these neurotransmitters so they will not become too
prominent. If they were, it might result in excess neural firing and
"manic" behaviour. Conversely, if MAO builds up to a higher level,
there may be a deficit of neurotransmitters as the MAO does its job
too well. gerovital`s reported capacity to balance MAO action may reduce
the problem.
In
contrast to many MAO inhibitors (where a tyramine-restricted diet
is needed) gerovital acts as a reversible inhibitor of MAO. It isolates
the MAO from the neurotransmitters and thus prevents there over
metabolisation. Under stress or in the presence of tyramine, the
procaine reverses this action so the MAO can perform its other necessary
functions.
- HOW
DOES OSTEOPOROSIS RESPOND TO GEROVITAL ?
Osteoporosis
is primarily caused by a breakdown of bone structure and a loss of
calcified tissue. It generally advances with age and therefore usually
is identified with geriatric patients. However NASA physicians reported
that space travellers in the weightless condition showed an alarming
advance of osteoporosis. gerovital treated patients have shown a significant
reduction in osteoporosis.
Results
have been reported both in preventing and reversing it gerovital apparently
encourages the body to retain calcium. Further, researchers report
that over a period of several years remineralization of the whole
skeleton can occur. A general thickening of the bones has been noted
in patients treated with gerovital as well. gerovital may improve osteoporosis
by its stimulation of the estrogens and androgens as previously
documented. These two hormones currently are used as treatments
for the condition.
-
CAN
GEROVITAL DO ANYTHING FOR SICKLE-CELL ANAEMIA?
Researchers
in one laboratory study showed that, when exposed to procaine, sickled
cells would re-oxygenate. They concluded that procaine competes
with calcium for membrane binding sites. Calcium is believed largely
responsible for the brittle form of haemoglobin. This was a laboratory
study only. However, the investigators took the position that procaine
held promise for controlling sickle-cell deformity.
-
WHAT
EFFECT DOES GEROVITAL HAVE ON BLOOD SUGAR ABNORMALITIES?
There
is no extensive data on the subject. One study showed easier management
of blood sugar level in diabetics using gerovital as an adjunct to insulin.
It also suggested that blood sugar levels tended to become normal
in cases where the values were aberrated slightly.
-
WILL
GEROVITAL l HELP REDUCE STRESS?
gerovital
exhibits anti-adrenergic properties and functions as a muscle relaxant.
Both these factors may provide greater resistance to stress. As
already explained, DEAE participates in the production of acetylcholine,
the counterpart of adrenaline. gerovital facilitates both the elimination
of toxins and the inhibition of excess MAO. Researchers consider
these factors aspects of stress reduction as well.
-
DOES
GH3 HELP MULTIPLE SCLEROSIS PATIENTS?
DR
Gohbrandt , a West German surgeon, conducted a clinical trial with
87 multiple sclerosis patients. The gerovital treated subjects showed
"remarkable improvement" No extensive clinical investigation has
been undertaken in this area.
-
WHAT
WILL GH3 DO FOR BODY WEIGHT?
Once
again, gerovital may act as a balancing factor,. Clearly patients in a
state of degeneration may fail to maintain a minimum safe body weight.
Some geriatric patients, for example gradually "waste" away as they
lose lean tissue. Studies demonstrate that the anabolic properties
of gerovital can promote weight gain. At the same time , a slow metabolic
rate can result in the failure to catabolize undesired body fat.
Clinical inquiry suggests that gerovital increases a deficient basal metabolic
rate.
|